FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | A-Z Index | Contact FDA

horizonal rule

Dockets Management

 

Dockets Entered On 05/23/2003

      Docket # Title

1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use

1980N-0145B Safety & Efficacy Review for OTC Ophthalmic Drug Prod.

2001D-0221 Biological Product Deviation Reporting for Licensed Manufact

2002N-0204 Bar Code Label Requirements for human drug products

2002N-0528 Risk Management Workshop, April 9-11, 2003 [PDUFA III]

2003D-0092 Food and Cosmetic Security Guidances

2003N-0134 Team Biologics Program Effectiveness; Public Meeting

2003N-0169 Dental Amalgam; Request for Information

2003P-0140 Refrain from Approving ANDAs for Topical Mupirocin Ointment

2003P-0160 FDA to send letter ruling refusing to approve loratadine tab

2003P-0196 Switch Nicotrol Inhaler - Prescription - Over the Counter Status

2003P-0214 Correctlisting-of Quinidine extended-release tablets in

Orange Book

2003P-0216 ANDA for a drug product(1.5 mg levonorgestrel tablet) in

strength(Plan B 0.75 mg Levonorgestrel tablet) in strength 

    1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use

      LET 40 HFD-1 to CTFA & SDA Vol #: 149

    1980N-0145B Safety & Efficacy Review for OTC Ophthalmic Drug Prod.

 

      C 1 American Academy of Ophthalmology (AAO) Vol #: 1

 

      1983V-0151 LASER LIGHT SHOW

 

      EXP 9 Precision Projection Systems Inc. Vol #: 1

 

      1988N-0038 Records & Reports concerning experience w/ new animal drugs

 

      REF 2 OMB Review Vol #: 3

 

      1996N-0417 CGMP in Mfg. Packing or Holding Dietary Supplements

 

      C 110 Ralph Fucetola, JD Vol #: 7

    2001D-0221 Biological Product Deviation Reporting for Licensed Manufact

      C 8 Merck & Co., Inc. Vol #: 1

 

      2002E-0149 Genesis Neurostimulation System, U.S. Patent No. 4,793,353

 

      LET 3 Advanced Neuromodulation Systems (ANS) Vol #: 1

    2002N-0204 Bar Code Label Requirements for human drug products

      C 44 Novartis Consumer Health, Inc. (NCH) Vol #: 13

 

      2002N-0278 Bioterrorism; Prior Notice of Imported Food Shipments

 

      M 2 HF-1 to Dockets Managemet Branch Vol #: 14

    2002N-0528 Risk Management Workshop, April 9-11, 2003 [PDUFA III]

      TR 3 Transcript for the 04/11/2003 Vol #: 6

    2003D-0092 Food and Cosmetic Security Guidances

      C 2 National Restaurant Assn Vol #: 1

 

      2003N-0069 FDA Task Force on Consumer Health Info for Better Nutrition

 

      EC 61 BROWN SR., GIDEON Vol #: 2

    2003N-0134 Team Biologics Program Effectiveness; Public Meeting

      C 1 Gen-Probe, Inc. Vol #: 1

    2003N-0169 Dental Amalgam; Request for Information

      M 1 HFZ-1 Vol #: 1

    2003P-0140 Refrain from Approving ANDAs for Topical Mupirocin Ointment

     C 1 Heller, Ehrman, White & McAuliffe, LLP Vol #: 1

    2003P-0160 FDA to send letter ruling refusing to approve loratadine tab

      C 2 Novartis Consumer Health, Inc. Vol #: 1

    2003P-0196 Switch Nicotrol Inhaler - Prescription - Over the Counter Status

      CP 1 Pharmacists Planning Services, inc. Vol #: 1

    2003P-0214 Correctlisting-of Quinidine extended-release tablets in

      Orange Book

      ACK 1 HFA-305 to Mutual Pharmaceutical Company Vol #: 1

 

      CP 1 Mutual Pharmaceutical Company Vol #: 1

    2003P-0216 ANDA for a drug product(1.5 mg levonorgestrel tablet) in

      strength(Plan B 0.75 mg Levonorgestrel tablet) in strength

      CP 1 HRA Pharma Vol #: 1

 

      2003V-0055 Laser Light Skhow

 

      VRA 1 HFZ-300 to Top-Notch-Entertainment Vol #: 1

 

      2003V-0131 Laser Light Show

 

      VRA 1 HFZ-300 to Laser Design Productions Vol #: 1

 

      2003V-0215 Laser Light Show

 

      ACK 1 HFA-305 to U.S. Air Force Research Laboratory Vol #: 1

 

      VAR 1 US Air Force Research Laboratory Vol #: 1

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility